ALT and AST are enzymes that work inside cells, and the blood test measures the small amount that leaks into circulation. ALT is concentrated mainly in liver cells. AST sits in the liver too, but also in skeletal muscle, heart muscle, kidney tissue and red blood cells. When cells are stressed, inflamed or turning over faster than usual, more enzyme reaches the bloodstream and the measured level climbs. A raised value therefore tells you that leakage has increased somewhere, not what caused it. Both are run from a routine venous draw, usually alongside ALP, GGT, bilirubin and albumin on the same panel. For the full detail on what ALT is, how the test is performed and how to read a single result, the ALT biomarker page covers that ground.
Because the liver is one of the main places thyroid hormone does its work, and when that signal weakens, liver metabolism shifts. Reviews of thyroid hormone and the liver describe the organ as a major target of thyroid hormone, where the hormone influences how fat is made, burned and exported 1. Research suggests that thyroid hormone signalling in liver cells shapes fatty acid oxidation, cholesterol and bile acid handling, and the turnover of worn components inside the cell 2.
When that signalling falls away, the balance tips toward storage. Work on hypothyroidism-induced fatty liver describes reduced fat burning combined with increased fat accumulation inside liver cells as part of how the picture develops 3. Fat sitting inside liver cells is not inert. It can be accompanied by low-grade inflammation and cell stress, and stressed liver cells leak more ALT and AST into the blood. That is the most common route by which thyroid status shows up on a liver panel.
There is a second layer. Thyroid hormone also influences body composition, circulating lipids and how the body handles glucose, and those same factors feed into liver fat. So a low thyroid state can nudge liver enzymes both directly, through hepatic signalling, and indirectly, through the wider metabolic picture it helps shape. Neither route produces a dramatic result in most people. The typical pattern is a modest rise, enough to stand out on a panel but not enough to explain itself.
No. Many people with an underactive thyroid have ALT and AST sitting comfortably inside the reference range, and a normal liver panel says nothing against a thyroid problem. The two tests answer different questions. TSH and free T4 describe thyroid signalling. ALT and AST describe cellular leakage from liver and, for AST, from other tissues too.
It also runs the other way. A mildly raised ALT does not point at the thyroid by default, because the thyroid is only one of several reasons a liver enzyme drifts up. What makes thyroid function worth checking is that it is cheap to measure, common enough to matter, and treatable in the hands of a clinician, so leaving it unexamined in an unexplained case would be an odd gap.
When enzyme elevations do appear alongside low thyroid function, they are usually modest rather than striking. A sharply raised ALT or AST, several times above the top of the reference range, generally sends a clinician looking at a wider set of possibilities rather than settling on the thyroid as the single answer. Scale matters as much as direction.
Fat accumulation in liver cells is the clearest link between the two organs. An updated meta-analysis found that primary hypothyroidism is associated with metabolic dysfunction-associated steatotic liver disease 4. The naming here has shifted in recent years, with metabolic dysfunction-associated steatotic liver disease, abbreviated MASLD, increasingly used in place of the older term nonalcoholic fatty liver disease, or NAFLD. Different papers use different labels for broadly the same condition.
The relationship appears to be graded rather than all-or-nothing. A dose-response meta-analysis of thyroid function and nonalcoholic fatty liver disease reported that the odds of fatty liver tracked with thyroid function across its range, not only at the point where thyroid disease is formally labelled 5. Research on hypothyroidism-induced fatty liver sets out how reduced thyroid hormone action inside liver cells can favour fat storage over fat clearance 3.
Why does this matter for ALT and AST? Because fat in the liver is one of the more frequent explanations for a mildly raised ALT on a routine panel in the first place. If low thyroid function makes liver fat more likely, it also makes the mild enzyme elevation that often accompanies liver fat more likely. The enzyme is downstream of the fat, and the fat is partly downstream of the hormone signal. That chain is why a liver panel and a thyroid panel often get read side by side rather than separately.
Yes, and this is one of the more useful distinctions to understand. AST is present in skeletal muscle, heart muscle, kidney and red blood cells, not just hepatocytes. An AST that is raised while ALT stays within range raises the question of whether the signal is coming from muscle at all. Low thyroid function can involve muscle symptoms such as aching, stiffness, cramps and slow recovery from exertion, and muscle that is unhappy can release AST.
This is why a clinician looking at an AST-dominant pattern may add creatine kinase, a marker that is far more specific to muscle, to the next draw. A high CK alongside a high AST and a normal ALT points toward muscle as the source. A raised ALT alongside the AST points back toward the liver. Recent hard training, a new resistance programme or a long endurance session can produce the same muscle-dominant pattern in someone with a perfectly ordinary thyroid, which is why timing of the blood draw relative to exercise is worth mentioning to whoever ordered the test.
If you want the background on how this particular enzyme is measured and reported, the guide to what is sgot ast blood test covers the naming and the mechanics. The practical point is simple. AST on its own is an ambiguous signal, and it becomes much more informative when read next to ALT, CK and the rest of the panel.
A mild elevation generally means a value sitting just above the top of the laboratory reference range rather than multiples above it. Here is how the ALT numbers typically look.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| ALT, adults in general | 7 to 56 U/L | 10 to 25 U/L |
| ALT, men | 7 to 56 U/L | 10 to 25 U/L |
| ALT, women | 7 to 33 U/L | 8 to 19 U/L |
Reference ranges vary by laboratory, age and sex, so the numbers printed on your own report are the ones that apply to your sample. The optimal ranges shown here are FitScript's optimization targets, not diagnostic cut-offs, and a value outside them is a prompt for a conversation rather than a verdict. AST reference ranges also differ between laboratories and between men and women, so read the range printed next to your own result rather than a generic figure.
Two things are worth noticing. First, standard reference ranges are wide, and a value can sit inside the range while still being well above where it used to be for that person. A trend from 14 to 38 U/L is invisible if you only check whether each value is flagged. Second, the reference range is a description of how a reference population tested, not a statement that everything inside it is ideal. That gap between normal and optimal is exactly where repeat testing earns its keep.
The useful companions fall into two groups, thyroid markers and liver or metabolic markers.
On the thyroid side, TSH is the usual first measure, with free T4 and often free T3 to describe how much hormone is actually circulating, and thyroid peroxidase antibodies when an autoimmune cause is in question. On the liver side, ALP and GGT describe the bile duct side of the system, bilirubin reflects processing and clearance, and albumin plus the clotting profile say something about synthetic capacity. Platelet count is worth watching over time because it drifts in chronic liver conditions.
The metabolic markers matter because liver fat and metabolic health travel together. Fasting glucose, HbA1c, fasting insulin, triglycerides, HDL and waist measurement all help describe whether the liver is sitting in a metabolically stressed environment. Ferritin and iron studies, viral hepatitis serology and a handful of autoimmune liver markers often get added when the picture stays unexplained. Creatine kinase belongs on the list whenever AST outruns ALT.
No single one of these confirms anything. Read together, they turn a lone flagged value into a pattern, and patterns are what clinicians actually act on. This is one reason broad panels repeated over time tend to be more informative than a single enzyme checked in isolation.
Because thyroid disease is common, easy to measure, and capable of influencing liver results, so leaving it out of an unexplained workup risks missing something straightforward. Reviews of the interplay between the thyroid and the liver set out why both organs are considered together in clinical practice, including the way thyroid dysfunction can show up in liver biochemistry 6.
There is also a pragmatic logic to the order of testing. When a mildly raised ALT or AST appears on a panel, the standard approach is to work through the explanations that are common, inexpensive to test for, and reversible before moving to the rarer or more invasive investigations. Thyroid function sits firmly in that first group. A TSH and free T4 cost little, require no preparation and can redirect the whole investigation if they come back outside range.
The reverse order happens too. In people already known to have low thyroid function, a liver panel often forms part of routine monitoring, because the metabolic consequences of the thyroid state do not stop at the thyroid. Research describes thyroid hormone as a regulator of hepatic lipid handling, which is the reason the liver is watched at all in this context 1.
Yes, and this is the part most people miss. The liver is where a large share of the conversion from T4 to the more active T3 takes place, and it produces the binding proteins that carry thyroid hormone through the bloodstream. Research on thyroid hormone action and liver disease describes the relationship as a complex two-way interplay rather than a one-way effect 7.
That means significant liver disease can change the numbers on a thyroid panel without the thyroid gland itself being the problem. Altered conversion and altered binding protein levels can shift free and total hormone measurements, which is why thyroid results drawn during an acute illness or in advanced liver disease are interpreted with extra caution. Reviews of the thyroid and liver relationship address exactly this problem of reading one organ's tests while the other is under strain 6. Studies suggest that the crosstalk runs through shared metabolic pathways in both directions, with the liver acting on thyroid hormone and thyroid hormone acting on the liver 2.
The practical consequence is that a single abnormal thyroid value in someone with a disturbed liver panel is not automatically a thyroid diagnosis, and a single abnormal liver value in someone with a disturbed thyroid panel is not automatically a liver diagnosis. Sequence and repetition sort this out. A clinician decides which test to repeat first and when.
Plenty, which is why the thyroid is one line of inquiry rather than the conclusion. The usual suspects include fat accumulation in the liver linked to metabolic health, alcohol intake, viral hepatitis, inherited conditions affecting iron or copper handling, autoimmune liver conditions, bile duct problems and coeliac disease. Some medicines and over-the-counter supplements can also move liver enzymes, which is one reason a clinician asks for a full list of everything you take, including things bought without a prescription.
Non-disease factors matter too. Intense or unaccustomed exercise in the days before a draw can raise AST and sometimes ALT through muscle release. Rapid changes in body weight, a recent viral illness, and the handling of the blood sample itself, such as haemolysis in the tube, can all nudge a result. Body composition and sex both influence where a person's baseline sits, which is part of why reference ranges differ for men and women.
None of this means an abnormal result should be brushed aside. It means the sensible response to one flagged enzyme is a careful history, a look at the rest of the panel and a repeat test, rather than either alarm or dismissal. The job of the first result is to raise the question. The job of the follow-up is to answer it.
Because biological markers move. ALT and AST fluctuate with recent activity, illness, alcohol, body weight changes and ordinary day-to-day variation, so a single value just above the range is a snapshot rather than a trend. A repeat draw some weeks later, under similar conditions, often tells a clearer story than agonising over the first one.
The shape of the change carries information too. An enzyme that was 18 U/L two years ago, 26 U/L last year and 41 U/L today is saying something different from one that has bounced around the high thirties for a decade. A rise that keeps rising deserves more attention than a stable value sitting slightly above a cut-off. This is why serial testing with consistent conditions, similar time of day, similar gap since the last hard training session, is more useful than one-off checks.
The ratio between the two enzymes adds another layer. An ALT-dominant pattern tends to direct attention to the liver. An AST-dominant pattern raises the muscle question and sometimes other possibilities a clinician will consider. Neither ratio is a diagnosis, and both are read alongside the rest of the panel, the history and the examination.
The honest answer runs in three steps. The observation is that one or both enzymes are above the laboratory range. The possible meaning, in people with hypothyroidism, is that the elevation may reflect liver fat associated with the low thyroid state, muscle involvement releasing AST, an unrelated liver cause running in parallel, or simple variation in a single measurement. The next step is a conversation with a clinician who can weigh the whole picture.
What it does not mean is that a diagnosis has been made. No single enzyme value identifies a disease, and the presence of a thyroid condition does not make the thyroid the automatic explanation for every out-of-range result. An unexplained enzyme elevation in someone with a known thyroid condition is still an unexplained enzyme elevation until the workup says otherwise.
What a clinician typically weighs includes how far above range the value sits, whether ALT or AST leads, what the rest of the liver panel shows, the thyroid numbers themselves, alcohol and medication history, body composition and metabolic markers, and whether there are symptoms. From there they decide whether to repeat the test, extend the panel, arrange imaging or look in a different direction entirely. Any decision about management, including any prescription therapy, is made by a licensed provider after evaluating the person in front of them.
Some findings deserve a conversation sooner rather than at the next routine review. Yellowing of the skin or eyes, dark urine, pale stools, persistent pain in the upper right abdomen, unexplained swelling, easy bruising, confusion or marked ongoing fatigue are all reasons to contact a clinician promptly, whatever the numbers say. A liver enzyme sitting several times above the top of the reference range is also worth raising promptly rather than waiting.
More routine reasons to book a conversation include an enzyme that has climbed steadily across several panels, a persistently suboptimal value that has not moved after a repeat test, a liver panel that is abnormal alongside thyroid numbers outside range, or an AST that keeps outrunning ALT without a clear exercise explanation. Symptoms of low thyroid function such as cold intolerance, weight change, dry skin, hair thinning, constipation and low mood belong in that same conversation, because they help a clinician read the labs in context.
Never ignore an abnormal result, and never assume a known thyroid condition accounts for it without checking. Discuss your results and any next step with a clinician or licensed provider who can see the whole picture.
It helps because the question is rarely answered by one marker. Reading a liver panel next to a thyroid panel, metabolic markers and a muscle marker turns a single flagged enzyme into a pattern with a direction, and patterns are what get acted on. Repeating that set over time adds the dimension that a one-off test cannot give, which is movement.
FitScript's approach is labs-first, with 150+ biomarkers tested per year, interpretation by Atlas, its AI health advisor, and any treatment decision made by a licensed provider who reviews the member first. The value of that structure for a question like this one is continuity. The same markers, drawn under comparable conditions, repeated often enough to show a trajectory rather than a snapshot.
This page is educational and is not medical advice.
For more on reading a single enzyme result and the point at which a value shifts from a curiosity to a conversation, see the guide on when to worry about alt levels.
It can be one explanation for a mild elevation, but it is not the only one and it is never confirmed by a single value. A clinician looks at how far above range the result sits, which enzyme is leading, the rest of the liver panel and your thyroid numbers before drawing any conclusion.
When enzymes do rise in this setting, the pattern is usually modest rather than striking. A result sitting several times above the top of the laboratory range generally prompts a wider search for other causes rather than being attributed to the thyroid, and it is worth discussing with a clinician promptly.
Repeat testing is the only way to find out in any individual case. A clinician or licensed provider decides what to recheck, when, and whether anything else needs investigating alongside it. Comparing like with like, such as a similar time of day and a similar gap since hard exercise, makes the comparison more useful.
It is a reasonable thing to raise. TSH and free T4 are inexpensive, need no preparation and sit in the first group of checks for an unexplained liver enzyme. The ordering clinician decides which tests to add and in what order.
A normal TSH makes a significant thyroid problem less likely, but clinicians often look at free T4 and sometimes free T3 and thyroid antibodies as well, especially when symptoms do not fit the numbers. Interpreting thyroid tests during an acute illness is harder, which is another reason timing is discussed with your clinician.
It depends on the source. ALT is concentrated mainly in liver cells, so an ALT-dominant pattern tends to direct attention to the liver. AST is also present in muscle, heart and red blood cells, so an AST-dominant pattern with a normal ALT raises the question of a non-liver source and often leads to a creatine kinase test.
Autoimmune thyroid conditions and autoimmune liver conditions can occur in the same person, which is one reason a clinician may extend the workup beyond the obvious when liver enzymes stay unexplained. Deciding which additional tests are appropriate is a clinical judgement, not something a single result can answer.
Liver enzymes alone do not usually require fasting, but they are often drawn as part of a wider panel that includes glucose or lipids, which may. Follow the instructions given by the laboratory or the clinician who ordered the draw.
Yes. Intense or unaccustomed training in the days before a draw can raise AST, and sometimes ALT, through muscle release. Leaving a few easy days before the test and telling your clinician about recent training makes the result far easier to interpret.